724788-78-7

Basic information

• Product Name: (5-({[4-(methyloxy)phenyl]methyl}oxy)-4-{[(trifluoromethyl)sulfonyl]oxy}-2-pyridinyl)methyl acetate
• Synonyms: (5-({[4-(methyloxy)phenyl]methyl}oxy)-4-{[(trifluoromethyl)sulfonyl]oxy}-2-pyridinyl)methyl acetate
• CAS NO: 724788-78-7
• Molecular Weight: 435.378
• Mol File: 724788-78-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (5-({[4-(methyloxy)phenyl]methyl}oxy)-4-{[(trifluoromethyl)sulfonyl]oxy}-2-pyridinyl)methyl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: (5-({[4-(methyloxy)phenyl]methyl}oxy)-4-{[(trifluoromethyl)sulfonyl]oxy}-2-pyridinyl)methyl acetate(724788-78-7)
• EPA Substance Registry System: (5-({[4-(methyloxy)phenyl]methyl}oxy)-4-{[(trifluoromethyl)sulfonyl]oxy}-2-pyridinyl)methyl acetate(724788-78-7)

Safety Data

• Hazardous Substances Data: 724788-78-7(Hazardous Substances Data)

Upstream product

• 724788-77-6 [5-({[4-(methyloxy)phenyl]methyl}oxy)-4-oxo-1,4-dihydro-2-pyridinyl]methyl acetate 
• 358-23-6 trifluoromethylsulfonic anhydride 

Downstream Products

• 952587-18-7 {5-({[4-(methyloxy)phenyl]methyl}oxy)-4-[(trimethylsilyl)ethynyl]-2-pyridinyl}methyl acetate 
• 724788-79-8 [4-[(1,1-dimethylethyl)thio]-5-({[4-(methoxy)phenyl]methyl}oxy)-2-pyridinyl]methyl acetate 
• 478148-60-6 furo[2,3-c]pyridin-5-yl methanol 
• 872715-05-4 2,3-dihydrofuro[2,3-c]pyridine-5-carbaldehyde 
• 944407-44-7 2H,3H-furo[2,3-c]pyridin-5-ylmethanol 

Relevant articles and documents

The design of efficient and selective routes to pyridyl analogues of 2,3-dihydro-1,4-benzodioxin-6-carbaldehyde

This Letter describes the synthetic routes to challenging pyridyl analogues of 2,3-dihydro-1,4-benzodioxin- 6-carbaldehyde which were key intermediates for our antibacterial medicinal chemistry programme. All routes described started from kojic acid (8) and have been used to give multigram quantities of each aldehyde.

ANTIBACTERIAL AGENTS

Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.